Susquehanna International Group
ALBO

Susquehanna International Group’s Albireo Pharma Inc ALBO Stock Holding History

Susquehanna International Group’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-21,100
Closed -$456K – 14085
2022
Q4 		$456K Sell
21,100
-5,500
-21% -$116K ﹤0.01% 8103
2022
Q3 		$515K Sell
26,600
-48,500
-65% -$1M ﹤0.01% 8413
2022
Q2 		$1.49M Sell
75,100
-53,100
-41% -$1.4M ﹤0.01% 5552
2022
Q1 		$3.82M Buy
128,200
+107,500
+519% +$3.15M ﹤0.01% 4164
2021
Q4 		$482K Sell
20,700
-54,100
-72% -$1.44M ﹤0.01% 9313
2021
Q3 		$2.33M Buy
74,800
+34,300
+85% +$1.06M ﹤0.01% 5516
2021
Q2 		$1.43M Buy
40,500
+16,700
+70% +$543K ﹤0.01% 6802
2021
Q1 		$839K Buy
23,800
+9,800
+70% +$362K ﹤0.01% 8183
2020
Q4 		$525K Sell
14,000
-51,700
-79% -$1.88M ﹤0.01% 8182
2020
Q3 		$2.19M Buy
65,700
+35,600
+118% +$1.04M ﹤0.01% 4442
2020
Q2 		$797K Sell
30,100
-3,700
-11% -$87.3K ﹤0.01% 6406
2020
Q1 		$553K Buy
+33,800
New +$743K ﹤0.01% 6710
2015
Q2 		– Sell
-403
Closed -$14K – 10580
2015
Q1 		$14K Buy
+403
New +$17K ﹤0.01% 9292
2014
Q3 		– Sell
-513
Closed -$33K – 10087
2014
Q2 		$33K Buy
+513
New +$35.7K ﹤0.01% 9656
2014
Q1 		– Sell
-897
Closed -$61K – 9570
2013
Q4 		$61K Sell
897
-1,130
-56% -$82.8K ﹤0.01% 8762
2013
Q3 		$191K Buy
2,027
+1,420
+234% +$185K ﹤0.01% 7803
2013
Q2 		$76K Buy
+607
New +$63.2K ﹤0.01% 7877

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's ALBO Position: Q4 2022 in Review

Susquehanna International Group sold out of Albireo Pharma Inc (ALBO) in Q4 2022, closing a stake of 36,525 shares — an estimated $772K sold.

Susquehanna International Group first reported a position in ALBO in Q2 2013 and held it in 23 quarters. The position peaked at $3.25M in Q2 2021. 96 funds tracked by Wall St. Rank hold ALBO as of Q4 2022.

  • Susquehanna International Group reported no remaining Albireo Pharma Inc position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 36,525 Albireo Pharma Inc shares in Q4 2022, an estimated $772K.
  • Susquehanna International Group first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 23 quarters.
  • Susquehanna International Group's Albireo Pharma Inc position peaked at $3.25M in Q2 2021.
  • 96 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.